{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:39:23Z","timestamp":1787495963338,"version":"build-2736575974"},"reference-count":41,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reports"],"abstract":"<jats:p>Background\u00a0and Clinical Significance: Statins are widely prescribed for cardiovascular risk reduction and generally demonstrate a favorable safety profile. While myalgia and elevations in liver enzymes are well-recognized adverse effects, headaches are less commonly reported and often underrecognized in clinical practice. This may result in unnecessary diagnostic evaluations, increased healthcare costs, and delayed identification of the underlying cause. Case Presentation: We describe an adult patient who developed intractable headaches that emerged after many years of statin therapy. The headaches persisted despite conventional analgesic treatment and resolved completely following discontinuation of the statin. Secondary causes were excluded, and comorbid conditions were systematically ruled out. Statin-associated headache is uncommon but clinically relevant. Proposed mechanisms include nitric-oxide-mediated vasodilation, central effects of lipophilic statins, and mitochondrial involvement. In this case, the patient was taking metoprolol succinate, lisinopril, simvastatin, clopidogrel, and tamsulosin. Except for lisinopril, none of the other comedications are strongly linked to new-onset headaches. Holding it did not resolve his headache, making simvastatin the most plausible contributor. This was confirmed by resolution of headache through its discontinuation. Because such headaches may be overlooked, clinicians should consider a statin-related cause when symptoms begin after initiation and may manage this by switching to a hydrophilic statin or using alternative lipid-lowering therapy. Conclusions: Clinicians should remain vigilant about the possibility of statin-induced headache, even in long-term users. Early recognition can prevent unnecessary diagnostic investigations, expedite symptom resolution, and support optimal management of both cardiovascular risk and treatment-related adverse effects.<\/jats:p>","DOI":"10.3390\/reports9010007","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:22:27Z","timestamp":1766578947000},"page":"7","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Statin-Associated Headache: A Rare and Underrecognized Clinical Presentation: A Case Report"],"prefix":"10.3390","volume":"9","author":[{"given":"Mohammad. I.","family":"Ullah","sequence":"first","affiliation":[{"name":"University of Mississippi Medical Center,  2500 N State St., Jackson, MS 39216, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadeka","family":"Tamanna","sequence":"additional","affiliation":[{"name":"G. V. (Sonny) Montgomery VA Medical Center,  1500 E Woodrow Wilson Ave., Jackson, MS 39216, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e050675","DOI":"10.1136\/bmjopen-2021-050675","article-title":"Statin associated adverse reactions in Latin America: A scoping review","volume":"11","year":"2021","journal-title":"BMJ Open"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"n1537","DOI":"10.1136\/bmj.n1537","article-title":"Associations between statins and adverse events in primary prevention of cardiovascular disease: Systematic review with pairwise, network, and dose-response meta-analyses","volume":"374","author":"Cai","year":"2021","journal-title":"BMJ"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Attardo, S., Musumeci, O., Velardo, D., and Toscano, A. (2022). Statins Neuromuscular Adverse Effects. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158364"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/17512433.2024.2311875","article-title":"Statin-related neurocognitive disorder: A real-world pharmacovigilance study based on the FDA adverse event reporting system","volume":"17","author":"Xiao","year":"2024","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/106002800303700220","article-title":"Association of HMG-CoA reductase inhibitors with neuropathy","volume":"37","author":"Backes","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of Migraine: A Disorder of Sensory Processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiol. Rev."},{"key":"ref_7","first-page":"682","article-title":"Approach to acute headache in adults","volume":"87","author":"Hainer","year":"2013","journal-title":"Am. Fam. Physician"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jama.287.1.92","article-title":"Does this patient have temporal arteritis?","volume":"287","author":"Smetana","year":"2002","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-022-00415-0","article-title":"Medication overuse headache","volume":"9","author":"Ashina","year":"2023","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1474-4422(18)30085-1","article-title":"International Classification of Headache Disorders","volume":"17","author":"Olesen","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: Impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-Associated Side Effects","volume":"67","author":"Thompson","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","article-title":"Statin adverse effects: A review of the literature and evidence for a mitochondrial mechanism","volume":"8","author":"Golomb","year":"2008","journal-title":"Am. J. Cardiovasc. Drugs Drugs Devices Interv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0038-1646946","article-title":"The Global Burden of Headache","volume":"38","author":"Saylor","year":"2018","journal-title":"Semin. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2008-1040951","article-title":"Neuroimaging in presumed primary headache disorders","volume":"17","author":"Frishberg","year":"1997","journal-title":"Semin. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ncl.2019.08.001","article-title":"Diagnostic Testing for Migraine and Other Primary Headaches","volume":"37","author":"Evans","year":"2019","journal-title":"Neurol. Clin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1468-2982.2004.00798.x","article-title":"Neuroimaging in the evaluation of patients with non-acute headache","volume":"25","author":"Sempere","year":"2005","journal-title":"Cephalalgia Int. J. Headache"},{"key":"ref_18","first-page":"1219","article-title":"Evidence-Based Guidelines for Neuroimaging in Patients with Nonacute Headache","volume":"71","author":"Neff","year":"2005","journal-title":"Am. Fam. Physician"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1468-1331.2010.03212.x","article-title":"Neurophysiological tests and neuroimaging procedures in non-acute headache (2nd edition)","volume":"18","author":"Sandrini","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"American Headache Society (2019). The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice. Headache, 59, 1\u201318.","DOI":"10.1111\/head.13456"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.amjmed.2003.10.033","article-title":"Current overview of statin-induced myopathy","volume":"116","author":"Rosenson","year":"2004","journal-title":"Am. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"III32","DOI":"10.1002\/clc.4960261507","article-title":"Pharmacologic characteristics of statins","volume":"26","author":"McKenney","year":"2003","journal-title":"Clin. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/0118715303324204240905111835","article-title":"Safety Profile of Statins for Post-Marketing Adverse Cardiovascular Events: A Real-World Pharmacovigilance Analysis","volume":"25","author":"Li","year":"2025","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12659\/AJCR.948601","article-title":"Delayed-Onset Rhabdomyolysis of Bilateral Lower Extremities Following Statin Therapy in a 63-Year-Old Woman: A Case Report","volume":"26","author":"Nguyen","year":"2025","journal-title":"Am. J. Case Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/14740338.2024.2424438","article-title":"Real-world safety evaluation of atorvastatin: Insights from the US FDA adverse event reporting system (FAERS)","volume":"24","author":"Wan","year":"2025","journal-title":"Expert. Opin. Drug Saf."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0167-5273(02)00195-X","article-title":"Beyond lipid lowering: The role of statins in vascular protection","volume":"86","author":"Liao","year":"2002","journal-title":"Int. J. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: An update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.phrs.2015.07.008","article-title":"Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trials","volume":"99","author":"Banach","year":"2015","journal-title":"Pharmacol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"SEARCH Collaborative Group, Link, E., Parish, S., Armitage, J., Bowman, L., Heath, S., Matsuda, F., Gut, I., Lathrop, M., and Collins, R. (2008). SLCO1B1 variants and statin-induced myopathy\u2013a genomewide study. N. Engl. J. Med., 359, 789\u2013799.","DOI":"10.1056\/NEJMoa0801936"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1526-4610.2008.01181.x","article-title":"Lack of association of endothelial nitric oxide synthase polymorphisms and migraine","volume":"48","author":"Toriello","year":"2008","journal-title":"Headache"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11916-009-0065-2","article-title":"Migraine headache in perimenopausal and menopausal women","volume":"13","author":"MacGregor","year":"2009","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/01213011-200512000-00004","article-title":"Genetic variability of CYP2B6 in populations of African and Asian origin: Allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz","volume":"15","author":"Klein","year":"2005","journal-title":"Pharmacogenet Genom."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction","volume":"338","author":"Goldstein","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3959(89)90067-5","article-title":"Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics","volume":"38","author":"Iversen","year":"1989","journal-title":"Pain"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"42M","DOI":"10.1016\/j.amjcard.2005.07.011","article-title":"Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: Focus on alpha-blocker interactions","volume":"96","author":"Kloner","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"ref_37","first-page":"17","article-title":"Calcium channel blockers: Differences between subclasses","volume":"7","author":"Frishman","year":"2007","journal-title":"Am. J. Cardiovasc. Drugs Drugs Devices Interv."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1526-4610.2008.01176.x","article-title":"Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse","volume":"48","author":"Calhoun","year":"2008","journal-title":"Headache"},{"key":"ref_39","first-page":"22","article-title":"SSRI Antidepressant Medications: Adverse Effects and Tolerability","volume":"3","author":"Ferguson","year":"2001","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1517\/14740338.3.5.495","article-title":"Safety and side effect profile of fluoxetine","volume":"3","author":"Wernicke","year":"2004","journal-title":"Expert. Opin. Drug Saf."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.61.4.490","article-title":"Topiramate in migraine prevention: Results of a large controlled trial","volume":"61","author":"Silberstein","year":"2004","journal-title":"Arch. Neurol."}],"container-title":["Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/1\/7\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:52:41Z","timestamp":1766580761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/1\/7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["reports9010007"],"URL":"https:\/\/doi.org\/10.3390\/reports9010007","relation":{},"ISSN":["2571-841X"],"issn-type":[{"value":"2571-841X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}